Charlotte Hedin1, Christopher J van der Gast2, Geraint B Rogers3, Leah Cuthbertson2, Sara McCartney4, Andrew J Stagg5, James O Lindsay6, Kevin Whelan7. 1. Faculty of Life Sciences & Medicine, Diabetes and Nutritional Sciences Division, King's College London, London, UK Centre for Immunology and Infectious Disease, Blizard Institute, Queen Mary University of London, London, UK. 2. NERC Centre for Ecology & Hydrology, Wallingford, Oxfordshire, UK. 3. South Australian Health and Medical Research Institute, Infection and Immunity Theme, Flinders University, Adelaide, Australia. 4. Centre for Gastroenterology and Nutrition, University College London, London, UK. 5. Centre for Immunology and Infectious Disease, Blizard Institute, Queen Mary University of London, London, UK. 6. Centre for Digestive Diseases, Blizard Institute, Queen Mary University of London, London, UK Department of Gastroenterology, Barts Health NHS Trust, London, UK. 7. Faculty of Life Sciences & Medicine, Diabetes and Nutritional Sciences Division, King's College London, London, UK.
Abstract
OBJECTIVE: To determine the existence of mucosal dysbiosis in siblings of patients with Crohn's disease (CD) using 454 pyrosequencing and to comprehensively characterise and determine the influence of genotypical and phenotypical factors, on that dysbiosis. Siblings of patients with CD have elevated risk of developing CD and display aspects of disease phenotype, including faecal dysbiosis. Whether the mucosal microbiota is disrupted in these at-risk individuals is unknown. DESIGN: Rectal biopsy DNA was extracted from 21 patients with quiescent CD, 17 of their healthy siblings and 19 unrelated healthy controls. Mucosal microbiota was analysed by 16S rRNA gene pyrosequencing and were classified into core and rare species. Genotypical risk was determined using Illumina Immuno BeadChip, faecal calprotectin by ELISA and blood T-cell phenotype by flow cytometry. RESULTS: Core microbiota of both patients with CD and healthy siblings was significantly less diverse than controls. Metacommunity profiling (Bray-Curtis (SBC) index) showed the sibling core microbial composition to be more similar to CD (SBC=0.70) than to healthy controls, whereas the sibling rare microbiota was more similar to healthy controls (SBC=0.42). Faecalibacterium prausnitzii contributed most to core metacommunity dissimilarity both between siblings and controls, and between patients and controls. Phenotype/genotype markers of CD risk significantly influenced microbiota variation between and within groups, of which genotype had the largest effect. CONCLUSIONS: Individuals with elevated CD-risk display mucosal dysbiosis characterised by reduced diversity of core microbiota and lower abundance of F. prausnitzii. This dysbiosis in healthy people at risk of CD implicates microbiological processes in CD pathogenesis. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
OBJECTIVE: To determine the existence of mucosal dysbiosis in siblings of patients with Crohn's disease (CD) using 454 pyrosequencing and to comprehensively characterise and determine the influence of genotypical and phenotypical factors, on that dysbiosis. Siblings of patients with CD have elevated risk of developing CD and display aspects of disease phenotype, including faecal dysbiosis. Whether the mucosal microbiota is disrupted in these at-risk individuals is unknown. DESIGN: Rectal biopsy DNA was extracted from 21 patients with quiescent CD, 17 of their healthy siblings and 19 unrelated healthy controls. Mucosal microbiota was analysed by 16S rRNA gene pyrosequencing and were classified into core and rare species. Genotypical risk was determined using Illumina Immuno BeadChip, faecal calprotectin by ELISA and blood T-cell phenotype by flow cytometry. RESULTS: Core microbiota of both patients with CD and healthy siblings was significantly less diverse than controls. Metacommunity profiling (Bray-Curtis (SBC) index) showed the sibling core microbial composition to be more similar to CD (SBC=0.70) than to healthy controls, whereas the sibling rare microbiota was more similar to healthy controls (SBC=0.42). Faecalibacterium prausnitzii contributed most to core metacommunity dissimilarity both between siblings and controls, and between patients and controls. Phenotype/genotype markers of CD risk significantly influenced microbiota variation between and within groups, of which genotype had the largest effect. CONCLUSIONS: Individuals with elevated CD-risk display mucosal dysbiosis characterised by reduced diversity of core microbiota and lower abundance of F. prausnitzii. This dysbiosis in healthy people at risk of CD implicates microbiological processes in CD pathogenesis. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Maria Eduarda T Oliveira; Gustavo V B Paulino; Erivaldo D Dos Santos Júnior; Francisca A da Silva Oliveira; Vânia M M Melo; Jeferson S Ursulino; Thiago M de Aquino; Ashok K Shetty; Melissa Fontes Landell; Daniel Leite Góes Gitaí Journal: Mol Neurobiol Date: 2022-08-13 Impact factor: 5.682
Authors: Byron P Vaughn; Tommi Vatanen; Jessica R Allegretti; Aiping Bai; Ramnik J Xavier; Joshua Korzenik; Dirk Gevers; Amanda Ting; Simon C Robson; Alan C Moss Journal: Inflamm Bowel Dis Date: 2016-09 Impact factor: 5.325
Authors: Alexandra Zhernakova; Alexander Kurilshikov; Marc Jan Bonder; Ettje F Tigchelaar; Melanie Schirmer; Tommi Vatanen; Zlatan Mujagic; Arnau Vich Vila; Gwen Falony; Sara Vieira-Silva; Jun Wang; Floris Imhann; Eelke Brandsma; Soesma A Jankipersadsing; Marie Joossens; Maria Carmen Cenit; Patrick Deelen; Morris A Swertz; Rinse K Weersma; Edith J M Feskens; Mihai G Netea; Dirk Gevers; Daisy Jonkers; Lude Franke; Yurii S Aulchenko; Curtis Huttenhower; Jeroen Raes; Marten H Hofker; Ramnik J Xavier; Cisca Wijmenga; Jingyuan Fu Journal: Science Date: 2016-04-28 Impact factor: 47.728